Elizabeth M. Gore, MD

Publications

• Feasibility of real-time lung tumor motion monitoring using intrafractional ultrasound and kV cone beam projection images.

  (Mostafaei F, Tai A, Gore E, Johnstone C, Haase W, Ehlers C, Cooper DT, Lachaine M, Li XA.) Med Phys. 2018 Jul 26.

• Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

  (Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H.) JAMA Oncol. 2018 Sep 01;4(9):1263-1266.

• Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review.

  (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA.) Neurosurgery. 2018 May 01;82(5):595-603.

• Select Patients With Limited Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively.

  (Gore EM.) Int J Radiat Oncol Biol Phys. 2018 May 01;101(1):6-7.

• Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408.

  (Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H.) Adv Radiat Oncol. 2017 Oct-Dec;2(4):608-614.

• Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.

  (Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD.) J Thorac Oncol. 2017 Oct;12(10):1561-1570.

• Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.

  (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD.) J Thorac Oncol. 2017 Sep;12(9):1413-1420.

• Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.

  (Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM, Gore E, Li XA.) Int J Radiat Oncol Biol Phys. 2017 06 01;98(2):463-472.

• Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.

  (Smith ZL, Gonzaga JE, Haasler GB, Gore EM, Dua KS.) Dig Dis Sci. 2017 06;62(6):1647-1656.

• Technical Note: Is bulk electron density assignment appropriate for MRI-only based treatment planning for lung cancer?

  (Prior P, Chen X, Gore E, Johnstone C, Li XA.) Med Phys. 2017 Jul;44(7):3437-3443.

• SU-F-J-162: Is Bulky Electron Density Assignment Appropriatefor MRI-Only Based Treatment Planning for Lung Cancer?

  (Prior P, Chen X, Johnstone C, Gore E, Li X.) Med Phys. 2016 Jun;43(6):3445.

• SU-F-R-54: CT-Texture Based Early Tumor Treatment Response Assessment During Radiation Therapy Delivery: Small Cell Versus Non-Small Cell Lung Cancers.

  (Paul J, Gore E, Li X.) Med Phys. 2016 Jun;43(6):3385.